LABCORP HOLDINGS INC. Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge
LABCORP HOLDINGS INC. (LH) reported Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge of -$32.80 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Income Statement › Other Income
us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1 · last filed 2022-02-25
- LABCORP HOLDINGS INC. change in unrealized gain (loss) on hedged item in fair value hedge for the quarter ending 2020-12-31 was -$28.40M.
- LABCORP HOLDINGS INC. change in unrealized gain (loss) on hedged item in fair value hedge for the quarter ending 2020-09-30 was -$23.10M, a 222.87% decline year-over-year.
- LABCORP HOLDINGS INC. change in unrealized gain (loss) on hedged item in fair value hedge for the quarter ending 2020-06-30 was -$8.80M.
- LABCORP HOLDINGS INC. change in unrealized gain (loss) on hedged item in fair value hedge for the quarter ending 2020-03-31 was $19.90M, a 55.47% increase year-over-year.
- LABCORP HOLDINGS INC. change in unrealized gain (loss) on hedged item in fair value hedge for fiscal 2021 was -$32.80M.
- LABCORP HOLDINGS INC. change in unrealized gain (loss) on hedged item in fair value hedge for fiscal 2020 was -$40.40M, a 773.33% decline from fiscal 2019.
- LABCORP HOLDINGS INC. change in unrealized gain (loss) on hedged item in fair value hedge for fiscal 2019 was $6.00M.
- LABCORP HOLDINGS INC. change in unrealized gain (loss) on hedged item in fair value hedge for fiscal 2018 was -$2.80M.
| Period end | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 3 month | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 6 month | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 9 month | Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$32.80M 10-K · filed 2022-02-25 | |||
| 2020-12-31 | -$28.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$51.50M derived: sum of 2 quarters · filed 2021-02-25 | -$60.30M derived: sum of 3 quarters · filed 2021-02-25 | -$40.40M 10-K · filed 2021-02-25 |
| 2020-09-30 | -$23.10M 10-Q · filed 2020-10-29 | -$31.90M derived: sum of 2 quarters · filed 2020-10-29 | -$12.00M 10-Q · filed 2020-10-29 | -$28.80M derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-06-30 | -$8.80M 10-Q · filed 2020-07-31 | $11.10M 10-Q · filed 2020-07-31 | -$5.70M derived: sum of 3 quarters · filed 2020-07-31 | $13.10M derived: sum of 4 quarters · filed 2020-07-31 |
| 2020-03-31 | $19.90M 10-Q · filed 2020-05-08 | $3.10M derived: sum of 2 quarters · filed 2020-05-08 | $21.90M derived: sum of 3 quarters · filed 2020-05-08 | $14.10M derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-12-31 | -$16.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $2.00M derived: sum of 2 quarters · filed 2020-02-28 | -$5.80M derived: sum of 3 quarters · filed 2020-02-28 | $6.00M 10-K · filed 2020-02-28 |
| 2019-09-30 | $18.80M 10-Q · filed 2019-10-31 | $11.00M derived: sum of 2 quarters · filed 2019-10-31 | $22.80M 10-Q · filed 2019-10-31 | $12.90M derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | -$7.80M 10-Q · filed 2019-08-08 | $4.00M 10-Q · filed 2019-08-08 | -$5.90M derived: sum of 3 quarters · filed 2019-08-08 | -$22.00M derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | $12.80M 10-Q · filed 2019-05-03 | $1.90M derived: sum of 2 quarters · filed 2019-05-03 | -$14.20M derived: sum of 3 quarters · filed 2019-05-03 | $10.10M derived: sum of 4 quarters · filed 2019-05-03 |
| 2018-12-31 | -$10.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$27.00M derived: sum of 2 quarters · filed 2019-02-28 | -$2.70M derived: sum of 3 quarters · filed 2019-02-28 | -$2.80M 10-K · filed 2019-02-28 |
| 2018-09-30 | -$16.10M 10-Q · filed 2018-10-30 | $8.20M derived: sum of 2 quarters · filed 2018-10-30 | $8.10M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $24.30M 10-Q · filed 2018-07-27 | $24.20M 10-Q · filed 2018-07-27 | ||
| 2018-03-31 | $100.00K 10-Q · filed 2018-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |